Norbert Ifrah
Norbert Ifrah publishes mostly in Hematology, Public Health, Environmental and Occupational Health and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research and Chronic Myeloid Leukemia Treatments.
- World rank
- #255,886 of 7,710,434 ranked researchers
- Rank in France
- #15,512 of 324,115
- Works
- 555
- Citations
- 24k
- Citations per work
- 42.9
What does Norbert Ifrah research?
Norbert Ifrah's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences35564.0%
- Medicine35564.0%
- Everything else15227.4%
- Life Sciences488.6%
- 1Hematology32% of their works
- 2Public Health, Environmental and Occupational Health12% of their works
- 3Molecular Biology9% of their works
- 4Genetics8% of their works
- 5Oncology7% of their works
- 6Pathology and Forensic Medicine5% of their works
Research topics
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Which keywords describe Norbert Ifrah's research?
The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Minimal Residual Disease, Acute Myeloid Leukemia, AML, Acute Lymphoblastic Leukemia, Childhood Cancer and Rituximab.
- Myelofibrosis
- International Myeloma Working Group
- Lymphoma
- Genomic Aberrations
- Graft-versus-Host Disease
- Imatinib
- Rituximab
- Acute Lymphoblastic Leukemia
- AML
- Hematopoietic Stem Cells
- Prognostic Factors
- Minimal Residual Disease
- Acute Myeloid Leukemia
- Childhood Cancer
- BCR-ABL
- Bone Marrow Niche
- Chronic Lymphocytic Leukemia
- Classification
- Diagnosis Criteria
- JAK2 Mutation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Prognostic Factors4323 topics
- Hematopoietic Stem Cells2782 topics
- Minimal Residual Disease2102 topics
- AML2031 topic
- Acute Myeloid Leukemia2031 topic
- Acute Lymphoblastic Leukemia1621 topic
- Childhood Cancer1621 topic
- Rituximab1302 topics
- BCR-ABL1131 topic
- Imatinib1131 topic
- Bone Marrow Niche751 topic
- Graft-versus-Host Disease751 topic
- Chronic Lymphocytic Leukemia671 topic
- Genomic Aberrations671 topic
- Classification631 topic
- Lymphoma631 topic
- Diagnosis Criteria481 topic
- International Myeloma Working Group481 topic
- JAK2 Mutation441 topic
- Myelofibrosis441 topic
Where does Norbert Ifrah work?
Norbert Ifrah's main affiliation in the publication record is Centre Hospitalier Universitaire d'Angers, France.
How many publications and citations does Norbert Ifrah have?
OpenAlex counts 555 works and 23,787 citations for Norbert Ifrah, an h-index of 80, ranking #255,886 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Norbert Ifrah. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.